Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation
This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most p...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Alexander Schuhmacher, Markus Hinder, Oliver Gassmann |
| description | This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program. |
| format | Book |
| fullrecord | <record><control><sourceid>proquest_askew</sourceid><recordid>TN_cdi_proquest_miscellaneous_2135831018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EBC4334757</sourcerecordid><originalsourceid>FETCH-LOGICAL-a46440-2bf02f407a370687ac4db0d64a223157fd6a447b7b7d37d57bb86308e853f7d33</originalsourceid><addsrcrecordid>eNqNkE9Lw0AQxVdEsdR-Ai-5qYfAZmf_5aihaqGgB-k1TJKJjd0mmt0ofntT24N4kjkM7_Hj8XhHbJYaC0oYnYJMxPEffcom6U4Ja9UZm3n_yjkXCaSGpxMWr9ANFGU9YWi6NmraKKwpelpjv8WShtCU6KJFWw0-9F_n7KRG52l2-FO2ups_Zw_x8vF-kd0sY5RaSh6LouailtwgGK6twVJWBa-0RCEgUaauNEppivEqMJUyRWE1cEtWQT1aMGVX--C3vnsfyId82_iSnMOWusHnY39lIeGJHdHrPYp-Q59-3bng8w9HRddtfP5rCtD_ZxMxspd_KvxgJbWhR5fPbzMJII0yI3lxIKl39NLlh7jd7Cl8A_0qdno</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>book</recordtype><pqid>EBC4334757</pqid></control><display><type>book</type><title>Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation</title><source>eBooks on EBSCOhost</source><creator>Alexander Schuhmacher, Markus Hinder, Oliver Gassmann</creator><creatorcontrib>Alexander Schuhmacher, Markus Hinder, Oliver Gassmann</creatorcontrib><description>This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.</description><edition>1</edition><identifier>ISBN: 9783527693412</identifier><identifier>ISBN: 3527693416</identifier><identifier>ISBN: 9783527339136</identifier><identifier>ISBN: 3527339132</identifier><identifier>EISBN: 9783527693412</identifier><identifier>EISBN: 3527693416</identifier><identifier>EISBN: 9783527693436</identifier><identifier>EISBN: 3527693432</identifier><identifier>OCLC: 935272885</identifier><language>eng</language><publisher>Newark: Wiley</publisher><subject>Biotechnology industry ; Business conditions ; Chemistry ; Economic conditions ; Pharmaceutical industry ; SCIENCE ; Strategic planning ; Technological innovations ; Value</subject><creationdate>2016</creationdate><tpages>542</tpages><format>542</format><rights>2016 John Wiley & Sons, Incorporated</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>307,782,786,788</link.rule.ids></links><search><creatorcontrib>Alexander Schuhmacher, Markus Hinder, Oliver Gassmann</creatorcontrib><title>Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation</title><description>This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.</description><subject>Biotechnology industry</subject><subject>Business conditions</subject><subject>Chemistry</subject><subject>Economic conditions</subject><subject>Pharmaceutical industry</subject><subject>SCIENCE</subject><subject>Strategic planning</subject><subject>Technological innovations</subject><subject>Value</subject><isbn>9783527693412</isbn><isbn>3527693416</isbn><isbn>9783527339136</isbn><isbn>3527339132</isbn><isbn>9783527693412</isbn><isbn>3527693416</isbn><isbn>9783527693436</isbn><isbn>3527693432</isbn><fulltext>true</fulltext><rsrctype>book</rsrctype><creationdate>2016</creationdate><recordtype>book</recordtype><sourceid>CCPQU</sourceid><recordid>eNqNkE9Lw0AQxVdEsdR-Ai-5qYfAZmf_5aihaqGgB-k1TJKJjd0mmt0ofntT24N4kjkM7_Hj8XhHbJYaC0oYnYJMxPEffcom6U4Ja9UZm3n_yjkXCaSGpxMWr9ANFGU9YWi6NmraKKwpelpjv8WShtCU6KJFWw0-9F_n7KRG52l2-FO2ups_Zw_x8vF-kd0sY5RaSh6LouailtwgGK6twVJWBa-0RCEgUaauNEppivEqMJUyRWE1cEtWQT1aMGVX--C3vnsfyId82_iSnMOWusHnY39lIeGJHdHrPYp-Q59-3bng8w9HRddtfP5rCtD_ZxMxspd_KvxgJbWhR5fPbzMJII0yI3lxIKl39NLlh7jd7Cl8A_0qdno</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Alexander Schuhmacher, Markus Hinder, Oliver Gassmann</creator><general>Wiley</general><general>John Wiley & Sons, Incorporated</general><general>Wiley-VCH</general><scope>YSPEL</scope><scope>CCPQU</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>2016</creationdate><title>Value Creation in the Pharmaceutical Industry</title><author>Alexander Schuhmacher, Markus Hinder, Oliver Gassmann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a46440-2bf02f407a370687ac4db0d64a223157fd6a447b7b7d37d57bb86308e853f7d33</frbrgroupid><rsrctype>books</rsrctype><prefilter>books</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biotechnology industry</topic><topic>Business conditions</topic><topic>Chemistry</topic><topic>Economic conditions</topic><topic>Pharmaceutical industry</topic><topic>SCIENCE</topic><topic>Strategic planning</topic><topic>Technological innovations</topic><topic>Value</topic><toplevel>online_resources</toplevel><creatorcontrib>Alexander Schuhmacher, Markus Hinder, Oliver Gassmann</creatorcontrib><collection>Perlego</collection><collection>ProQuest One Community College</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alexander Schuhmacher, Markus Hinder, Oliver Gassmann</au><format>book</format><genre>book</genre><ristype>BOOK</ristype><btitle>Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation</btitle><date>2016</date><risdate>2016</risdate><isbn>9783527693412</isbn><isbn>3527693416</isbn><isbn>9783527339136</isbn><isbn>3527339132</isbn><eisbn>9783527693412</eisbn><eisbn>3527693416</eisbn><eisbn>9783527693436</eisbn><eisbn>3527693432</eisbn><abstract>This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.</abstract><cop>Newark</cop><pub>Wiley</pub><oclcid>935272885</oclcid><tpages>542</tpages><edition>1</edition></addata></record> |
| fulltext | fulltext |
| identifier | ISBN: 9783527693412 |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2135831018 |
| source | eBooks on EBSCOhost |
| subjects | Biotechnology industry Business conditions Chemistry Economic conditions Pharmaceutical industry SCIENCE Strategic planning Technological innovations Value |
| title | Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-01T05%3A45%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_askew&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=book&rft.btitle=Value%20Creation%20in%20the%20Pharmaceutical%20Industry:%20The%20Critical%20Path%20to%20Innovation&rft.au=Alexander%20Schuhmacher,%20Markus%20Hinder,%20Oliver%20Gassmann&rft.date=2016&rft.isbn=9783527693412&rft.isbn_list=3527693416&rft.isbn_list=9783527339136&rft.isbn_list=3527339132&rft_id=info:doi/&rft_dat=%3Cproquest_askew%3EEBC4334757%3C/proquest_askew%3E%3Curl%3E%3C/url%3E&rft.eisbn=9783527693412&rft.eisbn_list=3527693416&rft.eisbn_list=9783527693436&rft.eisbn_list=3527693432&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=EBC4334757&rft_id=info:pmid/&rfr_iscdi=true |